Loading company…
Macera Therapeutics develops macrophage cell immunotherapies.
Macera Therapeutics researches treatments for solid tumors and fibrotic diseases using CAR-Macrophage technology. It also develops cell differentiation and molecular editing platforms. Founded in 2022 and based in Nanjing, China, the company closed venture funding from Fanchuang Capital and Dingxin Capital in May 2026.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in